Capital Impact Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-15,923
| Closed | -$2.38M | – | 112 |
|
2019
Q4 | $2.38M | Buy |
+15,923
| New | +$2.38M | 0.84% | 36 |
|
2019
Q3 | – | Sell |
-7,699
| Closed | -$1.06M | – | 125 |
|
2019
Q2 | $1.06M | Hold |
7,699
| – | – | 0.39% | 117 |
|
2019
Q1 | $937K | Hold |
7,699
| – | – | 0.42% | 119 |
|
2018
Q4 | $937K | Hold |
7,699
| – | – | 0.4% | 123 |
|
2018
Q3 | $1.28M | Hold |
7,699
| – | – | 0.44% | 115 |
|
2018
Q2 | $1.34M | Hold |
7,699
| – | – | 0.5% | 115 |
|
2018
Q1 | $1.16M | Buy |
7,699
+2,045
| +36% | +$309K | 0.48% | 116 |
|
2017
Q4 | $761K | Hold |
5,654
| – | – | 0.33% | 136 |
|
2017
Q3 | $827K | Sell |
5,654
-3,528
| -38% | -$516K | 0.37% | 138 |
|
2017
Q2 | $1.43M | Hold |
9,182
| – | – | 0.65% | 58 |
|
2017
Q1 | $1.33M | Buy |
9,182
+3,456
| +60% | +$502K | 0.53% | 104 |
|
2016
Q4 | $624K | Hold |
5,726
| – | – | 0.26% | 190 |
|
2016
Q3 | $696K | Hold |
5,726
| – | – | 0.3% | 185 |
|
2016
Q2 | $809K | Sell |
5,726
-12,105
| -68% | -$1.71M | 0.38% | 153 |
|
2016
Q1 | $2.33M | Buy |
17,831
+5,031
| +39% | +$657K | 1.11% | 2 |
|
2015
Q4 | $1.8M | Buy |
+12,800
| New | +$1.8M | 0.86% | 13 |
|
2014
Q2 | – | Sell |
-14,262
| Closed | -$1.98M | – | 224 |
|
2014
Q1 | $1.98M | Hold |
14,262
| – | – | 1.59% | 4 |
|
2013
Q4 | $1.81M | Buy |
+14,262
| New | +$1.81M | 1.45% | 7 |
|